Publicaciones
-
Planavila A, Redondo-Angulo I and Villarroya-Gombau F.
FGF21 and Cardiac Physiopathology.
Frontiers in Endocrinology . 6: 133-133. Nº de citas: 94
-
Planavila A, Redondo-Angulo I, Ribas F, Garrabou G, Casademont J, Giralt M and Villarroya-Gombau F.
Fibroblast growth factor 21 protects the heart from oxidative stress.
CARDIOVASCULAR RESEARCH . 106(1): 19-31. Nº de citas: 227
-
Gavaldà-Navarro A, Villena JA, Planavila A, Viñas O and Mampel T.
Expression of adenine nucleotide translocase (ANT) isoform genes is controlled by PGC-1a through different transcription factors.
JOURNAL OF CELLULAR PHYSIOLOGY . 229(12): 2126-2136. Nº de citas: 15
-
Villarroya-Terrade J, Flachs P, Redondo-Angulo I, Giralt M, Medrikova D, Villarroya-Gombau F, Kopecky J and Planavila A.
Fibroblast growth factor-21 and the beneficial effects of long-chain n-3 polyunsaturated fatty acids.
LIPIDS . 49(11): 1081-1089. Nº de citas: 21
-
Palomer FX, Capdevila-Busquets E, Alvarez-Guardia D, Barroso E, Pallàs M, Camins A, Davidson MM, Planavila A, Villarroya-Gombau F and Vazquez M.
Resveratrol induces nuclear factor-?B activity in human cardiac cells.
International Journal of Cardiology . 167(6): 2507-2516. Nº de citas: 33
-
Planavila A, Iglesias R, Giralt M and Villarroya-Gombau F.
Sirt1 acts in association with PPARa to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.
CARDIOVASCULAR RESEARCH . 90(2): 276-284. Nº de citas: 279
-
Amat R, Planavila A, Chen SL, Iglesias R, Giralt M and Villarroya-Gombau F.
SIRT1 controls the transcription of the peroxisome proliferator-activated receptor-gamma Co-activator-1alpha (PGC-1alpha) gene in skeletal muscle through the PGC-1alpha autoregulatory loop and interaction with MyoD.
JOURNAL OF BIOLOGICAL CHEMISTRY . 284(33): 21872-21880. Nº de citas: 189
-
Planavila A, Rodríguez-Calvo R, Palomer FX, Coll T, Sánchez RM, Merlos M, Laguna JC and Vazquez M.
Atorvastatin inhibits GSK-3beta phosphorylation by cardiac hypertrophic stimuli.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS . 1781(1-2): 26-35. Nº de citas: 16
-
Calls-Cobos A, Beà Tàrrega A, Cisneros A, Rommelfanger M, Campanario S, Grima-Terrén M, Ramírez-Pardo I, Moiseeva V, Lukesova V, Andrés E, Chou G, Zheng Y, Hah N, Blasco-Roset A, Planavila A, Soler-Botija C, Bayés-Genís A, Perdiguero E, Serrano AL and Muñoz-Cánoves P.
Senescence dynamics define therapeutic windows for Duchenne muscular dystrophy in DBA/2-mdx mice.
Skeletal Muscle . : .